# Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention

> **NCT04263844** · PHASE4 · COMPLETED · sponsor: **Indonesia University** · enrollment: 66 (actual)

## Conditions studied

- Emergence Delirium

## Interventions

- **DRUG:** Intranasal dexmedetomidine
- **DRUG:** Intranasal Midazolam

## Key facts

- **NCT ID:** NCT04263844
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-10
- **Primary completion:** 2019-10-10
- **Final completion:** 2019-10-10
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04263844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04263844, "Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04263844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*